Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of referenceConstantinos Zamboglou, Thomas F Fassbender, Lina Steffan, et al.
The Lancet. Oncology|August 1, 2024
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyMadeleine J Karpinski, Johannes Hüsing, Kevin Claassen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2020
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural NetworkDejan Kostyszyn, Tobias Fechter, Nico Bartl, et al.
Nuklearmedizin. Nuclear Medicine|June 2, 2026
German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025)Ralph Buchert, Philipp T Meyer, Nathalie L Albert, et al.
NPJ Parkinson'S Disease|June 26, 2026
A comprehensive assessment of lifecourse and mortality of Parkinson's disease in the German National CohortKlaus Berger, André Karch, Christina M Lill, et al.
The Lancet. Oncology|December 22, 2025
O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trialAnca-Ligia Grosu, Wolfgang A Weber, Erika Graf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2025
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 <sup>68</sup>Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient managementFrederik L Giesel, Stefan A Koerber, Boris Hadaschik, et al.
Nature Cancer|May 13, 2024
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndromeJanaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, et al.
JAMA|May 20, 2015
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysisRik Ossenkoppele, Willemijn J Jansen, Gil D Rabinovici, et al.
Annals of Neurology|September 27, 2018
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasiaDavid Bergeron, Maria L Gorno-Tempini, Gil D Rabinovici, et al.
Pageof 22